The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy
Author:
Funder
MEXT | Japan Society for the Promotion of Science
Japan Agency for Medical Research and Development
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-47799-w.pdf
Reference39 articles.
1. Chen, D. S. & Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity 39, 1–10 (2013).
2. Nakamura, T. & Harashima, H. Integration of nano drug-delivery system with cancer immunotherapy. Ther Deliv 8, 987–1000 (2017).
3. Huber, M. L., Haynes, L., Parker, C. & Iversen, P. Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer. J Natl Cancer Inst 104, 273–279 (2012).
4. Spranger, S. Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment. Int Immunol 28, 383–391 (2016).
5. Munn, D. H. & Bronte, V. Immune suppressive mechanisms in the tumor microenvironment. Curr Opin Immunol 39, 1–6 (2016).
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanodelivery Optimization of IDO1 Inhibitors in Tumor Immunotherapy: Challenges and Strategies;International Journal of Nanomedicine;2024-08
2. Impact of in vivo fate of STING agonist-loaded lipid nanoparticles on antitumor immunity;Journal of Controlled Release;2024-08
3. FLT3+ DC inhibits immune rejection via interaction with Treg in liver transplantation;International Immunopharmacology;2024-08
4. Recent Advances in Immune Regulation by Targeting Dendritic Cells using Small Interfering RNAs;Current Molecular Medicine;2024-06-07
5. The impact of, and expectations for, lipid nanoparticle technology: From cellular targeting to organelle targeting;Journal of Controlled Release;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3